Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to $391.4 million.

  • Madrigal Pharmaceuticals' Total Current Liabilities rose 12008.02% to $391.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.4 million, marking a year-over-year increase of 12008.02%. This contributed to the annual value of $169.3 million for FY2024, which is 4279.19% up from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Total Current Liabilities stood at $391.4 million for Q3 2025, which was up 12008.02% from $196.5 million recorded in Q2 2025.
  • Over the past 5 years, Madrigal Pharmaceuticals' Total Current Liabilities peaked at $391.4 million during Q3 2025, and registered a low of $48.8 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $125.5 million, with a median of $99.7 million in 2023.
  • As far as peak fluctuations go, Madrigal Pharmaceuticals' Total Current Liabilities surged by 75.31% in 2023, and later soared by 12008.02% in 2025.
  • Madrigal Pharmaceuticals' Total Current Liabilities (Quarter) stood at $76.8 million in 2021, then skyrocketed by 50.83% to $115.9 million in 2022, then grew by 2.29% to $118.5 million in 2023, then soared by 42.79% to $169.3 million in 2024, then skyrocketed by 131.22% to $391.4 million in 2025.
  • Its Total Current Liabilities was $391.4 million in Q3 2025, compared to $196.5 million in Q2 2025 and $167.2 million in Q1 2025.